These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 6183482)

  • 21. [Role of the prostaglandin-kinin system of the kidneys in the transport of sodium and water].
    Nekrasova AA; Sokolova RI; Levitskaia IuV; Zharova EA
    Kardiologiia; 1977 Mar; 17(3):108-14. PubMed ID: 301957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of diuretics on components of the urinary kallikrein-kininogen-kinin system in man.
    Weinberg MS; Blonsky SL; Solomon R
    Am J Hypertens; 1988 Jan; 1(1):27-30. PubMed ID: 3370133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of cicletanine on hypertension-induced decreases in the renal kallikrein-kinin and prostaglandin systems in stroke-prone spontaneously hypertensive rats.
    Emond C; Bompart G; Rakotoarivony J; Bascands JL; Pecher C; Adam A; Tarrade T; Berthet P; Girolami JP
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):601-8. PubMed ID: 1280717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amiloride, frusemide and urinary kallikrein excretion.
    Waller DG; Thakrar PM; Campbell SK
    Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):145-50. PubMed ID: 3446039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Participation of the prostaglandin system in furosemide-induced changes of renal function in anesthetized rats.
    Yoshida M; Suzuki-Kusaba M; Satoh S
    Ren Physiol; 1987; 10(1):25-32. PubMed ID: 2446364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A; Mantero F; Opocher G; Armanini D; Lechi C; Covi G
    J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
    Seto S; Kher V; Scicli AG; Beierwaltes WH; Carretero OA
    Hypertension; 1983; 5(6):893-9. PubMed ID: 6197374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of diuretics and non-steroidal anti-inflammatory drugs in man.
    Favre L; Glasson P; Riondel A; Vallotton MB
    Clin Sci (Lond); 1983 Apr; 64(4):407-15. PubMed ID: 6337769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathophysiological role of renal dopamine, kallikrein kinin and prostaglandin systems in essential hypertension.
    Iimura O; Shimamoto K; Ura N; Nakagawa M; Nishimiya T; Ando T; Yamaguchi Y; Masuda A; Ogata H; Saito S
    Agents Actions Suppl; 1987; 22():247-56. PubMed ID: 3324711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mineralocorticoid escape during kallikrein inhibition.
    Overlack A; Bäcker-Kreutz E; Ressel C; Müller HM; Kolloch R; Stumpe KO
    Clin Sci (Lond); 1986 Jan; 70(1):13-7. PubMed ID: 2417776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prostaglandin and kallikrein-kinin systems in mineralocorticoid escape.
    Zipser RD; Zia P; Stone RA; Horton R
    J Clin Endocrinol Metab; 1978 Nov; 47(5):996-1001. PubMed ID: 263798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of ureteral occlusion and renal venous constriction on kidney kallikrein-kinin and prostaglandin systems in dogs.
    Olsen UB
    Acta Physiol Scand; 1978 Dec; 104(4):443-52. PubMed ID: 726937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
    Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
    Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of atrial natriuretic peptide (ANP) on the renal kallikrein-kinin system in normotensive and spontaneously hypertensive rats].
    Bönner G; Hirzel B; Ganten D; Kaufmann W
    Z Kardiol; 1988; 77 Suppl 2():85-91. PubMed ID: 2841816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergic effects of kallikrein-kinin and prostaglandins on renin release on infusion of isolated hog kidney with aldosterone.
    Gotoh S; Ogihara T; Nakamaru M; Ohde H; Higaki J; Otsuka A; Tabuchi Y; Kumahara Y; Nishino T
    Life Sci; 1984 May; 34(20):1913-8. PubMed ID: 6203005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the renal kinin-prostaglandin system in diltiazem-induced natriuresis.
    Seino M; Abe K; Nushiro N; Omata K; Sato K; Tsunoda K; Yoshinaga K
    Am J Physiol; 1986 Feb; 250(2 Pt 2):F197-202. PubMed ID: 2418690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma and tissue kallikrein-kinin systems during acute administration of frusemide in normotensive and hypertensive humans.
    Ohman KP; Karlberg BE
    Clin Sci (Lond); 1991 Sep; 81(3):305-11. PubMed ID: 1655330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Bandiera F; Manunta P; Rubattu S; Rappelli A
    J Hypertens; 1987 Oct; 5(5):581-6. PubMed ID: 2448367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.